๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
This randomized phase II trial studies how well cediranib maleate and olapa...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2017-12-07
Trial ID
NCT02974621
Treatments Being Tested
ICON 9 will assess the efficacy, safety and tolerability of maintenance ola...
Status
Unknown
Location
Calvary Mater Hospital
Start Date
2018-06-15
Trial ID
NCT03278717
This randomized phase II/III trial studies how well cediranib maleate and o...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-03
Trial ID
NCT02502266
The COPELIA trial is evaluating two new tablet medications in endometrial c...
Status
Unknown
Location
Mount Vernon Cancer Centre
Start Date
2018-05-17
Trial ID
NCT03570437
Treatments Being Tested
This partially randomized phase I/II trial studies the side effects and the...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2010-04-14
Trial ID
NCT01116648
This phase III trial studies olaparib or cediranib maleate and olaparib to ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-03-28
Trial ID
NCT02446600
Treatments Being Tested
The trial will compare the drugs olaparib and cediranib with standard chemo...
Status
Completed
Location
Belfast City Hospital
Start Date
2017-03-09
Trial ID
NCT03117933
Treatments Being Tested
Ovarian cancer can often grow and cause obstructions in the bowel. These ob...
Status
Completed
Location
The Christie NHS Foundation Trust
Start Date
2018-05-14
Trial ID
NCT07648745
Treatments Being Tested
PARP inhibitors, such as olaparib, significantly improve progression free s...
Status
Completed
Location
The Christie NHS Foundation Trust
Start Date
2017-05-26
Trial ID
NCT02855697
Treatments Being Tested